National Institutes of Health (NIH) SBIR/STTR Awards

Venture Capital

The NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs — collectively known as America's Seed Fund — are U.S. federal grant programs that set aside more than $1.4 billion annually from NIH's R&D budget to fund early-stage small businesses developing biomedical and health innovations. Non-dilutive grants are awarded in phases: Phase I (~$323K, feasibility) and Phase II (~$2.15M, development). The NIH takes no equity ownership. Program focus areas include diagnostics, drugs, medical devices, digital health, and research tools.

Website

Pre-Seed

Seed

Biotech

Diagnostics

Medical Devices

digital_health

pharmaceuticals

research_tools

Headquarters: Bethesda, United States
Founded: 1982
Website: seed.nih.gov

AUM: $1.4B
Total Investment: 1
Geographic Focus: United States

Investment Thesis

Stimulate technological innovation in biomedical and health sciences by providing non-dilutive seed funding to early-stage U.S. small businesses, fostering participation by underrepresented and undercapitalized entrepreneurs, and increasing private-sector commercialization of federally funded R&D. The NIH retains no equity and is generally not the final purchaser of funded technologies.

National Institutes of Health (NIH) SBIR/STTR Awards is a Venture Capital firm based in Bethesda, United States. It has made 1 investment in Biotech and Diagnostics.

Investment History

Sign up to view investment history

Create a free account to see deal history, investment amounts, and round details.

Create Free Account